Who Supplies Pyrazinamide? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Pyrazinamide exports, with 90+ registered manufacturers shipping to buyers across 131+ countries — yet a handful of companies dominate the shipments. LUPIN LIMITED holds the largest share at 81.8% (export value: $786.8M). Close behind, MACLEODS PHARMACEUTICALS LTD (9.3%, $89.7M). MACLEODS PHARMACEUTICALS LIMITED (0.4%, $4.1M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Pyrazinamide? Top Manufacturers & Their Buyers
Flow of Pyrazinamide from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Pyrazinamide Supplier Network — Key Market Intelligence
The Pyrazinamide export market from India is led by LUPIN LIMITED, which alone commands a 81.8% share, shipping $786.8M worth of product across 321 shipments. The second-largest exporter, MACLEODS PHARMACEUTICALS LTD, contributes $89.7M (9.3%) to the overall market. Combined, the top two suppliers alone account for 91.1% of all Pyrazinamide exports, indicating a relatively concentrated supply base.
Across all 90 tracked manufacturers, the total Pyrazinamide export value stands at $962.4M from 1.5K shipments. The market average shipment value is $659.6K. The single largest buyer relationship in terms of trade value is CAMESKIN/CORDAID, receiving $532.0M worth of product.
The combined buyer network spans 25 named purchasing companies, including CAMESKIN/CORDAID, NATIONAL TUBERCULOSIS AND LEPROSY C, I+SOLUTIONS, SEKRETARIAT DITJEN PENCEGAHAN DAN P, DEPARTMENT OF HEALTH and 20 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1LUPIN LIMITED
LUPIN LIMITED is the first-largest Pyrazinamide exporter from India, with a market share of 81.8% and a total export value of $786.8M across 321 shipments. Their average shipment value of $2.5M is above the market average of $659.6K, suggesting premium or bulk contract pricing.
LUPIN LIMITED serves 5 named buyers in our database. CAMESKIN/CORDAID is the dominant customer, accounting for 67.6% of this supplier's tracked business. Top customers include:
• CAMESKIN/CORDAID — $532.0M across 217 shipments (67.6% of this supplier's total exports)
• NATIONAL TUBERCULOSIS AND LEPROSY C — $246.4M across 101 shipments (31.3% of this supplier's total exports)
• I+SOLUTIONS — $3.5M across 1 shipments (0.4% of this supplier's total exports)
• SEKRETARIAT DITJEN PENCEGAHAN DAN P — $2.6M across 1 shipments (0.3% of this supplier's total exports)
• DEPARTMENT OF HEALTH — $2.4M across 1 shipments (0.3% of this supplier's total exports)
Key Insight: LUPIN LIMITED's per-shipment value of $2.5M is 272% above the market average of $659.6K, consistent with large-order contracts or value-added formulations.
2MACLEODS PHARMACEUTICALS LTD
MACLEODS PHARMACEUTICALS LTD is the second-largest Pyrazinamide exporter from India, with a market share of 9.3% and a total export value of $89.7M across 361 shipments. Their average shipment value of $248.6K is below the market average of $659.6K, reflecting a high-volume, competitive pricing strategy.
MACLEODS PHARMACEUTICALS LTD serves 5 named buyers in our database. LA PHARMACIE CENTRALE DE TUNISIE is the dominant customer, accounting for 87.4% of this supplier's tracked business. Top customers include:
• LA PHARMACIE CENTRALE DE TUNISIE — $78.4M across 316 shipments (87.4% of this supplier's total exports)
• ATLANTA MEDICARE CO, — $3.5M across 14 shipments (3.9% of this supplier's total exports)
• MINISTRY OF HEALTH OF THE REPUBLIC — $3.4M across 14 shipments (3.8% of this supplier's total exports)
• MINISTERIO DA SAUDE/DEPARTAMENTO DE — $2.8M across 11 shipments (3.2% of this supplier's total exports)
• MEDECINS SANS FRONTIERES LOGISTIQUE — $1.6M across 6 shipments (1.7% of this supplier's total exports)
Key Insight: MACLEODS PHARMACEUTICALS LTD operates with high shipment frequency (361 shipments) at a per-shipment value of $248.6K, indicating a broad distribution network with many smaller, regular orders.
3MACLEODS PHARMACEUTICALS LIMITED
MACLEODS PHARMACEUTICALS LIMITED is the third-largest Pyrazinamide exporter from India, with a market share of 0.4% and a total export value of $4.1M across 143 shipments. Their average shipment value of $28.7K is below the market average of $659.6K, reflecting a high-volume, competitive pricing strategy.
MACLEODS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• NATIONAL COORDINATOR — $1.4M across 47 shipments (33.0% of this supplier's total exports)
• MACLEODS PHARMACEUTI — $922.2K across 32 shipments (22.5% of this supplier's total exports)
• ADVANCED PHARMACEUTI — $814.3K across 28 shipments (19.8% of this supplier's total exports)
• PERMANENT SECRETARY — $524.5K across 18 shipments (12.8% of this supplier's total exports)
• NA — $491.2K across 17 shipments (12.0% of this supplier's total exports)
Key Insight: MACLEODS PHARMACEUTICALS LIMITED operates with high shipment frequency (143 shipments) at a per-shipment value of $28.7K, indicating a broad distribution network with many smaller, regular orders.
4SVIZERA LABS PRIVATE LIMITED
SVIZERA LABS PRIVATE LIMITED is the fourth-largest Pyrazinamide exporter from India, with a market share of 0.3% and a total export value of $3.0M across 39 shipments. Their average shipment value of $75.9K is below the market average of $659.6K, reflecting a high-volume, competitive pricing strategy.
SVIZERA LABS PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• DR LABARAN SHEHU — $1.0M across 13 shipments (34.1% of this supplier's total exports)
• MOH- NATIONAL TB AND — $625.4K across 8 shipments (21.1% of this supplier's total exports)
• TO THE ORDER OF — $622.4K across 8 shipments (21.0% of this supplier's total exports)
• NATIONAL TUBERCULOSIS AND LEPROSY C — $541.2K across 7 shipments (18.3% of this supplier's total exports)
• MINISTERIO DE SALUD — $162.7K across 2 shipments (5.5% of this supplier's total exports)
Key Insight: SVIZERA LABS PRIVATE LIMITED operates with high shipment frequency (39 shipments) at a per-shipment value of $75.9K, indicating a broad distribution network with many smaller, regular orders.
5MANEESH PHARMACEUTICALS LIMITED
MANEESH PHARMACEUTICALS LIMITED is the fifth-largest Pyrazinamide exporter from India, with a market share of 0.3% and a total export value of $2.7M across 69 shipments. Their average shipment value of $39.3K is below the market average of $659.6K, reflecting a high-volume, competitive pricing strategy.
MANEESH PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• 5 KAMPALA — $822.1K across 21 shipments (30.3% of this supplier's total exports)
• SOCINTER- SOCIEDADE — $745.3K across 19 shipments (27.5% of this supplier's total exports)
• KENYA MEDICAL SUPPLIES AGENCY — $417.9K across 11 shipments (15.4% of this supplier's total exports)
• SEKRETARIAT DITJEN PENCEGAHAN DAN P — $390.0K across 10 shipments (14.4% of this supplier's total exports)
• KENYA MEDICAL SUPPLIES AGENCY — $335.0K across 9 shipments (12.4% of this supplier's total exports)
Key Insight: MANEESH PHARMACEUTICALS LIMITED operates with high shipment frequency (69 shipments) at a per-shipment value of $39.3K, indicating a broad distribution network with many smaller, regular orders.
6MICRO LABS LIMITED
MICRO LABS LIMITED is the fifth-largest Pyrazinamide exporter from India, with a market share of 0.1% and a total export value of $1.1M across 64 shipments. Their average shipment value of $16.5K is below the market average of $659.6K, reflecting a high-volume, competitive pricing strategy.
MICRO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• D.G. CENTRAL MEDICAL — $316.0K across 19 shipments (29.9% of this supplier's total exports)
• PROGRAMA DE LAS NACI — $266.0K across 16 shipments (25.1% of this supplier's total exports)
• PHARMACIE CENTRALE D — $194.3K across 12 shipments (18.4% of this supplier's total exports)
• PHARMACE NATIONALE — $167.0K across 10 shipments (15.8% of this supplier's total exports)
• THE MEDICAL EXPORT G — $114.7K across 7 shipments (10.8% of this supplier's total exports)
Key Insight: MICRO LABS LIMITED operates with high shipment frequency (64 shipments) at a per-shipment value of $16.5K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Pyrazinamide Flows
Once Pyrazinamide leaves the manufacturing plants of companies like LUPIN LIMITED and MACLEODS PHARMACEUTICALS LTD, it travels to 5 destination markets with a combined import value of $962.4M. Congo Dr absorbs the largest share at 55.5% ($534.5M), followed by Nigeria (26.0%) and Tunisia (8.2%).
This geographic spread reflects Pyrazinamide's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Pyrazinamide Go? Top Importing Countries & Their Buyers
Trade flow of Pyrazinamide exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Congo Dr
Congo Dr ranks as the first-largest destination for Pyrazinamide imports from India, with a total trade value of $534.5M across 0 shipments — representing a 55.5% share of all Pyrazinamide exports. The average shipment value of $534.5M is above the global average of $659.6K, indicating high-value procurement contracts or branded formulations.
Key Insight: Congo Dr's per-shipment average of $534.5M (80936% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Congo Dr is a key market for Pyrazinamide imports from India.
2Nigeria
Nigeria ranks as the second-largest destination for Pyrazinamide imports from India, with a total trade value of $250.0M across 44 shipments — representing a 26.0% share of all Pyrazinamide exports. The average shipment value of $5.7M is above the global average of $659.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Pyrazinamide importers in Nigeria: NATIONAL TUBERCULOSIS AND LEPROSY is the largest buyer, accounting for 98.9% ($247.2M) of this market's total imports.
• NATIONAL TUBERCULOSIS AND LEPROSY — $247.2M (98.9% of Nigeria's total)
• NATIONAL TUBERCULOSIS AND LEPROSY C — $1.7M (0.7% of Nigeria's total)
Key Insight: Nigeria's per-shipment average of $5.7M (761% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Nigeria is a key market for Pyrazinamide imports from India.
3Tunisia
Tunisia ranks as the third-largest destination for Pyrazinamide imports from India, with a total trade value of $78.5M across 3 shipments — representing a 8.2% share of all Pyrazinamide exports. The average shipment value of $26.2M is above the global average of $659.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Pyrazinamide importers in Tunisia: LA PHARMACIE CENTRALE DE TUNISIE is the largest buyer, accounting for 100.0% ($78.4M) of this market's total imports.
• LA PHARMACIE CENTRALE DE TUNISIE — $78.4M (100.0% of Tunisia's total)
Key Insight: Tunisia's per-shipment average of $26.2M (3866% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Tunisia is a key market for Pyrazinamide imports from India.
4Netherlands
Netherlands ranks as the fourth-largest destination for Pyrazinamide imports from India, with a total trade value of $9.7M across 52 shipments — representing a 1.0% share of all Pyrazinamide exports. The average shipment value of $187.0K is below the global average of $659.6K, consistent with generic/API volume purchasing. This market is served by 1 tracked buyer.
Named Pyrazinamide importers in Netherlands: I+SOLUTIONS is the largest buyer, accounting for 70.0% ($6.8M) of this market's total imports.
• I+SOLUTIONS — $6.8M (70.0% of Netherlands's total)
Key Insight: Netherlands receives frequent, smaller shipments of Pyrazinamide — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Netherlands is a key market for Pyrazinamide imports from India.
5South Africa
South Africa ranks as the fifth-largest destination for Pyrazinamide imports from India, with a total trade value of $8.6M across 35 shipments — representing a 0.9% share of all Pyrazinamide exports. The average shipment value of $246.7K is below the global average of $659.6K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.
Named Pyrazinamide importers in South Africa: UPD LEA GLEN is the largest buyer, accounting for 20.4% ($1.8M) of this market's total imports.
• UPD LEA GLEN — $1.8M (20.4% of South Africa's total)
• UPD LEA GLEN, PHARMA DYNAMICS C/O — $1.7M (20.2% of South Africa's total)
Key Insight: South Africa receives frequent, smaller shipments of Pyrazinamide — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
South Africa is a key market for Pyrazinamide imports from India.
People Also Ask — Pyrazinamide Supplier & Trade Network
Who are the top suppliers of Pyrazinamide from India?+
Which companies buy Pyrazinamide from Indian manufacturers?+
Where does Pyrazinamide exported from India go?+
What is the market share of the top Pyrazinamide supplier from India?+
What is the average shipment value for Pyrazinamide exports from India?+
Is Pyrazinamide manufactured in India and exported globally?+
Which country imports the most Pyrazinamide from India?+
Who are the buyers of Pyrazinamide in Nigeria?+
How concentrated is the Pyrazinamide supplier market in India?+
How do I find verified buyers for Pyrazinamide in specific countries?+
Pyrazinamide Trade Network — Key Takeaways
- 1LUPIN LIMITED is India's dominant Pyrazinamide exporter with a 81.8% market share and $786.8M in total exports — making it the single most important sourcing entity in this market.
- 2The top 90 suppliers collectively account for 92.2% of all tracked Pyrazinamide exports, with a combined trade value of $962.4M.
- 3Congo Dr is the largest destination market, absorbing 55.5% of India's Pyrazinamide exports ($534.5M). Nigeria (26.0%) and Tunisia (8.2%) follow.
- 4With 1.5K total shipments averaging $659.6K each, the Pyrazinamide export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include CAMESKIN/CORDAID, NATIONAL TUBERCULOSIS AND LEPROSY C, LA PHARMACIE CENTRALE DE TUNISIE, ATLANTA MEDICARE CO, — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 131 countries
Network value: $962.4M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Pyrazinamide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Pyrazinamide.
- 2.Flow Mapping: 90 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,459 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 131 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,459 Verified Shipments
90 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists